Artra-Synkoloid Surface Conditioner

Product Description

Surface Conditioner was a finishing and preparation product manufactured by Artra-Synkoloid, a company that produced a range of construction and building material products including joint compounds and surface treatment formulations. Products in this category were designed to condition, prime, or prepare surfaces prior to finishing, painting, or the application of additional coatings and compounds. Surface conditioners of this type were commonly used in commercial and industrial construction environments, where smooth, properly prepared substrates were required before final finishing work could proceed.

Artra-Synkoloid operated within the broader joint compound and finishing materials market, producing products that were distributed to construction sites, industrial facilities, and building trades. Surface conditioners in this product category were applied to walls, ceilings, and other structural surfaces, making them a routine part of construction and renovation workflows during the periods in which asbestos-containing building materials were widely used across American industry.

The specific years during which Artra-Synkoloid Surface Conditioner was produced are not fully established in publicly available records, but products of this nature were commonly manufactured and distributed during the mid-to-late twentieth century, a period when asbestos was a standard additive in many construction and finishing materials due to its binding, fire-resistant, and textural properties.

Asbestos Content

Litigation records document that Artra-Synkoloid Surface Conditioner was alleged to contain asbestos as a component of its formulation. Plaintiffs alleged that asbestos fibers were incorporated into the product during manufacturing, consistent with industry-wide practices of the era in which joint compounds, surface conditioners, and related finishing materials routinely included asbestos to improve product performance, workability, and durability.

Asbestos minerals commonly used in joint compounds and surface treatment products during this period included chrysotile (white asbestos) and, in some formulations, amphibole varieties such as tremolite or anthophyllite. These fibers were valued by manufacturers for their ability to bind with other materials, resist heat, and improve the texture and spreadability of finishing compounds. The specific fiber type or concentration present in Artra-Synkoloid Surface Conditioner has not been independently confirmed in publicly available regulatory documentation, but litigation records reflect plaintiffs’ allegations that the product contained asbestos at levels capable of generating hazardous fiber release during normal use.

As with other joint compound and surface conditioner products of the era, asbestos content was not always disclosed to end users, and many workers applied these materials without knowledge of the potential health hazard contained within them.

How Workers Were Exposed

Industrial workers generally represent the primary category of individuals documented in connection with exposure to Artra-Synkoloid Surface Conditioner. Litigation records document that workers who mixed, applied, sanded, or otherwise disturbed this product during construction, finishing, or renovation activities were placed at risk of inhaling airborne asbestos fibers.

Exposure pathways associated with surface conditioner products are well understood in occupational health literature. When dry powdered formulations are mixed with water, clouds of dust can be generated that contain respirable asbestos fibers. Similarly, when applied conditioners or compounds are sanded, scraped, or disturbed during surface preparation or demolition, previously settled fibers can become re-entrained in the air. Workers in enclosed or poorly ventilated spaces — common in both new construction and renovation environments — faced particularly elevated exposure levels because fibers had limited opportunity to dissipate.

Plaintiffs alleged that repeated, sustained exposure to airborne asbestos fibers released during the use of Artra-Synkoloid Surface Conditioner contributed to the development of serious asbestos-related diseases. The diseases most commonly associated with occupational asbestos exposure include:

  • Mesothelioma — an aggressive malignancy of the pleural lining of the lungs, the peritoneum, or other mesothelial surfaces, strongly and almost exclusively associated with asbestos exposure
  • Asbestosis — a progressive, fibrotic scarring of lung tissue caused by the accumulation of asbestos fibers, resulting in diminished lung capacity and respiratory impairment
  • Lung cancer — including both small cell and non-small cell types, for which asbestos exposure is a recognized contributing cause, particularly among smokers
  • Pleural disease — including pleural plaques, pleural thickening, and pleural effusions, which can impair respiratory function and serve as markers of significant prior asbestos exposure

OSHA has established a permissible exposure limit (PEL) for asbestos of 0.1 fibers per cubic centimeter of air as an eight-hour time-weighted average. However, industrial hygiene research has consistently demonstrated that construction finishing activities involving asbestos-containing materials — including mixing and sanding joint compounds and surface conditioners — could generate fiber concentrations far exceeding this threshold in the absence of appropriate controls. Many workers performing these tasks during the decades of peak asbestos use had no respiratory protection, no hazard warnings, and no awareness that the materials they were working with posed a latent but potentially fatal risk.

Because Artra-Synkoloid Surface Conditioner is a Tier 2 product under the classification framework used on this site, legal accountability has been pursued primarily through civil litigation rather than through an established asbestos bankruptcy trust fund. No dedicated Artra-Synkoloid asbestos trust fund has been identified in publicly available trust fund documentation maintained by the RAND Institute for Civil Justice or related legal databases.

Litigation records document that claims involving Artra-Synkoloid products, including Surface Conditioner, have been brought in asbestos dockets in state and federal courts. Plaintiffs alleged that the company manufactured and distributed a product containing asbestos without providing adequate warnings to workers who would foreseeably be exposed during normal product use. These claims have proceeded under legal theories including products liability (failure to warn and defective design), negligence, and, in cases involving surviving family members, wrongful death.

Individuals who believe they developed an asbestos-related illness as a result of exposure to Artra-Synkoloid Surface Conditioner or related products should be aware of the following:

  • Statutes of limitations govern asbestos personal injury claims and vary by state. These deadlines typically begin running at the date of diagnosis rather than the date of exposure, but prompt consultation with legal counsel is essential to preserve rights.
  • Multi-defendant claims are common in asbestos litigation because workers were frequently exposed to products from multiple manufacturers. A claim involving Artra-Synkoloid Surface Conditioner may also include claims against other product manufacturers, raw asbestos suppliers, or premises owners.
  • Trust fund claims may be available against other parties in a worker’s exposure history even where direct litigation against Artra-Synkoloid is the primary avenue for this specific product.
  • Documentation of exposure — including employment records, co-worker testimony, product identification records, and medical records — strengthens claims and should be gathered and preserved as early as possible.

Workers, former industrial employees, and their families who were exposed to Artra-Synkoloid Surface Conditioner are encouraged to consult with an attorney experienced in asbestos litigation to evaluate their legal options.

This article is provided for informational and reference purposes only and does not constitute legal advice. Information is based on documented litigation records, regulatory standards, and publicly available product documentation.